IMNM
NSCImmunome Inc.
Manufacturing•Pharmaceutical Preparation Manufacturing
Watchlists:
Last updated: Monday 21st July 2025
10.58
+0.13 (1.24%)
Prev Close:10.45
Open:10.49
Bid:10.6
Ask:11.15
52 Week Range
5.1516.81
Volume:998,590
Mkt Cap:731 M
51
MarketXLS Rank ®
Hold
Price Target
$12.17
+15.0%
Financial Statements
IMNM - Cash Flow (Annual)
| Dec-24 | Dec-23 | Dec-22 | Dec-21 | Dec-20 | Invalid date | |
|---|---|---|---|---|---|---|
| Asset Impairment Charge | -3 M | -512000.0 | ||||
| Capital Expenditure Reported | 7 M | 831000.0 | 248000.0 | 79000.0 | 586000.0 | |
| Cash Flow From Continuing Investing Activities | -85 M | -30 M | -248000.0 | -79000.0 | -586000.0 | |
| Change In Account Payable | 10 M | -608000.0 | -677000.0 | 2 M | 504000.0 | |
| Change In Payables And Accrued Expense | 10 M | -608000.0 | -677000.0 | 2 M | 504000.0 | |
| Change In Prepaid Assets | 906000.0 | -4 M | 5 M | -4 M | -2 M | |
| Change In Working Capital | 1 M | 11 M | 4 M | -3 M | -2 M | |
| Common Stock Payments | -559000.0 | -6 M | ||||
| Depreciation And Amortization | 2 M | 771000.0 | 631000.0 | 755000.0 | 755000.0 | |
| Financing Cash Flow | 241 M | 116 M | 32000.0 | 28 M | 50 M | |
| Interest Paid Supplemental Data | 14000.0 | 29000.0 | ||||
| Issuance Of Capital Stock | 20 M | 125 M | 1 M | 45 M | ||
| Issuance Of Debt | 500000.0 | |||||
| Net Business Purchase And Sale | -46 M | 9 M | ||||
| Net Common Stock Issuance | 20 M | 125 M | 779000.0 | -6 M | ||
| Net Investment Properties Purchase And Sale | -32 M | -39 M | ||||
| Net Investment Purchase And Sale | -32 M | -39 M | ||||
| Net Issuance Payments Of Debt | 500000.0 | |||||
| Net Long Term Debt Issuance | 500000.0 | |||||
| Net PPE Purchase And Sale | -7 M | -831000.0 | -248000.0 | -79000.0 | -586000.0 | |
| Net Preferred Stock Issuance | 11 M | |||||
| Other Non-cash Items | 179 M | 87 M | 3 M | 8 M | 7 M | |
| Preferred Stock Issuance | 11 M | |||||
| Proceeds From Issuance Of Warrants | 4 M | 27 M | 45 M | |||
| Proceeds From Stock Option Exercised | 2 M | 371000.0 | 32000.0 | 99000.0 | 20000.0 | |
| Purchase Of Investment | -187 M | -39 M | ||||
| Purchase Of PPE | -7 M | -831000.0 | -248000.0 | -79000.0 | -586000.0 | |
| Sale Of Business | 9 M | |||||
| Sale Of Investment | 155 M | |||||
| Stock Based Compensation | 16 M | 6 M | 5 M | 3 M | 621000.0 | |
| Unrealized Gain Loss On Investment Securities | 6 M | |||||
| Amord | 535000.0 | 271000.0 | 209000.0 | |||
| Begcash | 49 M | 40 M | 3 M | |||
| Capex | -7 M | -831000.0 | -248000.0 | -79000.0 | -586000.0 | |
| Cffcf | 241 M | 116 M | 32000.0 | 28 M | 50 M | |
| Cffinv | -85 M | -30 M | -248000.0 | -79000.0 | -586000.0 | |
| Cffoa | -111 M | -8 M | -29 M | -18 M | -12 M | |
| Chgcash | 45 M | 78 M | -29 M | 9 M | 37 M | |
| Chgothcl | -9 M | 16 M | ||||
| Chgothwc | 153000.0 | -229000.0 | ||||
| Chgpay | 10 M | -608000.0 | -677000.0 | 2 M | 504000.0 | |
| Comstkiss | 20 M | 125 M | 1 M | 45 M | ||
| Depamor | 2 M | 500000.0 | 400000.0 | 800000.0 | 800000.0 | |
| Endcash | 143 M | 78 M | 20 M | 49 M | 40 M | |
| Fcf | -118 M | -8 M | -29 M | -18 M | -13 M | |
| Ltdebtiss | 500000.0 | |||||
| Netinccont | -293 M | -107 M | -37 M | -25 M | -18 M | |
| Netothfin | 215 M | -9 M | -335000.0 | -451000.0 | ||
| Opcf | -111 M | -8 M | -29 M | -18 M | -12 M | |
| Purchbus | -46 M | |||||
| Purchsti | -187 M | -39 M | ||||
| Repurchstk | -559000.0 | -6 M | ||||
| Salesti | 155 M |